首页> 外文期刊>Chimica oggi: international journal of chemistry and biotechnology >cGMP commercial .scale oligonucleotide synthesis From equipment design concept to system qualification
【24h】

cGMP commercial .scale oligonucleotide synthesis From equipment design concept to system qualification

机译:cGMP商业规模的寡核苷酸合成从设备设计概念到系统鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

A fully automated flow-through synthesizer connected to a dynamic axial compression (DAC) column reactor was designed to perform commercial scale oligonucleotide synthesis. Aspects of the system design which support scale-up, tech transfer to/from other sites and alternative equipment designs are reviewed. The systems were extensively tested during manufacturing and start-up. Both the IQ (Installation Qualification) and the OQ (Operational Qualification) were modelled on the testing done by the system designer prior to delivery. The PQ (Performance Qualification) of the synthesizer was done synthesizing a "reference" oligonucleotide at full production scale for the instrument of 120 mmol. The same oligonucleotide had been previously made at Girindus on a different system at a smaller scale so a performance comparison could be made. Manufacturing science can be used to develop an understanding of a process and identify critical parameters that may affect a process. The high yield of the 13-mer oligonucleotide synthesized by the cGMP commercial scale synthesizer is an example of a controlled manufacturing process.
机译:连接到动态轴向压缩(DAC)柱反应器的全自动流通式合成器设计用于进行商业规模的寡核苷酸合成。审查了系统设计的各个方面,这些方面支持扩大规模,与其他站点之间的技术转让以及替代设备的设计。该系统在制造和启动期间都经过了广泛的测试。 IQ(安装资格认证)和OQ(操作资格认证)均以系统设计师在交付前所做的测试为模型。合成器的PQ(性能鉴定)是在120mmol的仪器的全生产规模下合成“参考”寡核苷酸。先前已在Girindus的较小系统上以较小的规模生产了相同的寡核苷酸,因此可以进行性能比较。制造科学可以用来加深对过程的理解,并确定可能影响过程的关键参数。由cGMP商业规模合成器合成的13聚体寡核苷酸的高收率是受控制造过程的一个示例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号